AVSuper's investment committee has appointed two new investment managers following a comprehensive review and due diligence.
Investment management company Martin Currie has been added to the fund's investment portfolio to manage a portion of AVSuper's emerging markets equities portfolio, while GMO will manage a portion of its defensive alternatives portfolio via the GMO Multi-Strategy Trust.
AVSuper investment committee officer Scott Malpass said Martin Currie's investment philosophy included a belief that market inefficiencies could be manipulated to maximise risk-adjusted returns.
"They provide a high-conviction, stock-focused portfolio driven by fundamental research," he said.
He said GMO targeted performance of UBS Australia Bank Bill Index plus 8 per cent with a standard deviation of 5 per cent.
"The Trust uses numerous underlying excess market (alpha) generating sources and seeks to achieve its investment objective with low volatility and correlation to traditional market indices," he said.
In February AVSuper awarded a $75 million mandate to Perpetual to manage a portion of its Australian equities portfolio.
A hold in the cash rate during the upcoming November monetary policy meeting appears to now be a certainty off the back of skyrocketing inflation during the September quarter.
The peak superannuation body has announced the appointment of Peter Chun, chief executive officer of UniSuper, to its Board of Directors.
Superannuation fees have continued their multi-year decline, as fund consolidation and index investing deliver scale efficiencies for members.
Super funds demand fast passage of payday super laws, while small business advocates warn of cash flow pressures and compliance risks.